{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:00:03Z","timestamp":1793761203787,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production. Here we develop three protein arrays to measure IgG autoantibodies associated with connective tissue diseases, anti-cytokine antibodies, and anti-viral antibody responses in serum from 147 hospitalized COVID-19 patients. Autoantibodies are identified in approximately 50% of patients but in less than 15% of healthy controls. When present, autoantibodies largely target autoantigens associated with rare disorders such as myositis, systemic sclerosis and overlap syndromes. A subset of autoantibodies targeting traditional autoantigens or cytokines develop de novo following SARS-CoV-2 infection. Autoantibodies track with longitudinal development of IgG antibodies recognizing SARS-CoV-2 structural proteins and a subset of non-structural proteins, but not proteins from influenza, seasonal coronaviruses or other pathogenic viruses. We conclude that SARS-CoV-2 causes development of new-onset IgG autoantibodies in a significant proportion of hospitalized COVID-19 patients and are positively correlated with immune responses to SARS-CoV-2 proteins.<\/jats:p>","DOI":"10.1038\/s41467-021-25509-3","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T06:02:59Z","timestamp":1631599379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":425,"title":["New-onset IgG autoantibodies in hospitalized patients with COVID-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Sarah Esther","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-0097","authenticated-orcid":false,"given":"Sokratis A.","family":"Apostolidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-494X","authenticated-orcid":false,"given":"Elisabeth","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Artandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-761X","authenticated-orcid":false,"given":"Linda","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-3757","authenticated-orcid":false,"given":"Saborni","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggie","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Chinthrajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaurya","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Finck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gaano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Ge\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-3806","authenticated-orcid":false,"given":"Heather M.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Greib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrit","family":"G\u00fcndisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Ren","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-5578","authenticated-orcid":false,"given":"Alex","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monali","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Neeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatosin","family":"Oniyide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Schapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton A.","family":"Weidenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-8329","authenticated-orcid":false,"given":"Richard","family":"Wittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Ryun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-758X","authenticated-orcid":false,"given":"Prasanna","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-4541","authenticated-orcid":false,"given":"Peter S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-5584","authenticated-orcid":false,"given":"Nuala J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-2955","authenticated-orcid":false,"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8004-282X","authenticated-orcid":false,"given":"Marko","family":"Radic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3894-685X","authenticated-orcid":false,"given":"Taia T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. John","family":"Wherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-5635","authenticated-orcid":false,"given":"Chrysanthi","family":"Skevaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-9211","authenticated-orcid":false,"given":"Eline T.","family":"Luning Prak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-1565","authenticated-orcid":false,"given":"Paul J.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"25509_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"25509_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395, 507\u2013513 (2020).","journal-title":"Lancet."},{"key":"25509_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi, J. et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J. Neuroimmune Pharm. 15, 359\u2013386 (2020).","journal-title":"J. Neuroimmune Pharm."},{"key":"25509_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-020-01316-3","volume":"43","author":"E Asfuroglu Kalkan","year":"2020","unstructured":"Asfuroglu Kalkan, E. & Ates, I. A case of subacute thyroiditis associated with Covid-19 infection. J. Endocrinol. Invest 43, 1173\u20131174 (2020).","journal-title":"J. Endocrinol. Invest"},{"key":"25509_CR5","doi-asserted-by":"publisher","unstructured":"Brancatella, A. et al. Subacute thyroiditis after Sars-COV-2 infection. J. Clin. Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa276 (2020).","DOI":"10.1210\/clinem\/dgaa276"},{"key":"25509_CR6","doi-asserted-by":"publisher","unstructured":"Carfi, A., Bernabei, R., Landi, F. & Gemelli Against, C.-P.-A. C. S. G. Persistent symptoms in patients after acute COVID-19. JAMA https:\/\/doi.org\/10.1001\/jama.2020.12603 (2020).","DOI":"10.1001\/jama.2020.12603"},{"key":"25509_CR7","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","volume":"175","author":"SY Patel","year":"2005","unstructured":"Patel, S. Y. et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J. Immunol. 175, 4769\u20134776 (2005).","journal-title":"J. Immunol."},{"key":"25509_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"M Woodruff","year":"2020","unstructured":"Woodruff, M. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\u20131516 (2020).","journal-title":"Nat. Immunol"},{"key":"25509_CR9","doi-asserted-by":"publisher","unstructured":"Woodruff, M. C., Ramonell, R. P., Lee, F. E. & Sanz, I. Relaxed peripheral tolerance drives broad de novo autoreactivity in severe COVID-19. medRxiv https:\/\/doi.org\/10.1101\/2020.10.21.20216192 (2021).","DOI":"10.1101\/2020.10.21.20216192"},{"key":"25509_CR10","doi-asserted-by":"publisher","unstructured":"Zuo, Y. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876 (2020).","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"25509_CR11","doi-asserted-by":"publisher","unstructured":"Gruber, C. N. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell https:\/\/doi.org\/10.1016\/j.cell.2020.09.034 (2020).","DOI":"10.1016\/j.cell.2020.09.034"},{"key":"25509_CR12","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s10067-020-05359-y","volume":"39","author":"H Fujii","year":"2020","unstructured":"Fujii, H. et al. High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: high levels of anti-SSA\/Ro antibodies in COVID-19. Clin. Rheumatol. 39, 3171\u20133175 (2020).","journal-title":"Clin. Rheumatol."},{"key":"25509_CR13","unstructured":"James, J. A. in Workshop on Post-Acute Sequelae of COVID-19. https:\/\/tracs.unc.edu\/index.php\/calendar\/83-other-sponsor\/1766-niaid-workshop-on-covid-19."},{"key":"25509_CR14","doi-asserted-by":"publisher","unstructured":"Barnes, B. J. et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20200652 (2020).","DOI":"10.1084\/jem.20200652"},{"key":"25509_CR15","doi-asserted-by":"publisher","unstructured":"Tomar, B., Anders, H. J., Desai, J. & Mulay, S. R. Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells https:\/\/doi.org\/10.3390\/cells9061383 (2020).","DOI":"10.3390\/cells9061383"},{"key":"25509_CR16","first-page":"e138999","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).","journal-title":"JCI Insight"},{"key":"25509_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang,","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"25509_CR18","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1172\/JCI70231","volume":"123","author":"JV Price","year":"2013","unstructured":"Price, J. V. et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J. Clin. Invest 123, 5135\u20135145 (2013).","journal-title":"J. Clin. Invest"},{"key":"25509_CR19","doi-asserted-by":"publisher","unstructured":"Rosenberg, J. M. et al. Neutralizing anti-cytokine autoantibodies against interferon-\u03b1 in immunodysregulation polyendocrinopathy enteropathy X-Linked. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00544 (2018).","DOI":"10.3389\/fimmu.2018.00544"},{"key":"25509_CR20","unstructured":"Ayoglu B, D. M. et al. Identification of unique autoantibody profiles in systemic sclerosis following hematopoietic stem cell transplantation. Sci. Transl. Med. in preparation."},{"key":"25509_CR21","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science, https:\/\/doi.org\/10.1126\/science.abd4585 (2020).","DOI":"10.1126\/science.abd4585"},{"key":"25509_CR22","doi-asserted-by":"publisher","first-page":"e64555","DOI":"10.1371\/journal.pone.0064555","volume":"8","author":"JV Price","year":"2013","unstructured":"Price, J. V. et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One 8, e64555 (2013).","journal-title":"PLoS One"},{"key":"25509_CR23","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.1128\/JVI.77.20.11125-11138.2003","volume":"77","author":"HE Neuman de Vegvar","year":"2003","unstructured":"Neuman de Vegvar, H. E. et al. Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J. Virol. 77, 11125\u201311138 (2003).","journal-title":"J. Virol."},{"key":"25509_CR24","doi-asserted-by":"publisher","first-page":"eabe0240","DOI":"10.1126\/sciimmunol.abe0240","volume":"5","author":"K R\u00f6ltgen","year":"2020","unstructured":"R\u00f6ltgen, K. et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci. Immunol. 5, eabe0240 (2020).","journal-title":"Sci. Immunol."},{"key":"25509_CR25","doi-asserted-by":"publisher","unstructured":"Vlachoyiannopoulos, P. G. et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann. Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218009 (2020).","DOI":"10.1136\/annrheumdis-2020-218009"},{"key":"25509_CR26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"25509_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"I-E Galani","year":"2021","unstructured":"Galani, I.-E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"25509_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0162-3109(94)90058-2","volume":"28","author":"LP Courtney","year":"1994","unstructured":"Courtney, L. P., Phelps, J. L. & Karavodin, L. M. An anti-IL-2 antibody increases serum halflife and improves anti-tumor efficacy of human recombinant interleukin-2. Immunopharmacology 28, 223\u2013232 (1994).","journal-title":"Immunopharmacology"},{"key":"25509_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01878084","volume":"6","author":"J Sato","year":"1993","unstructured":"Sato, J. et al. Enhancement of anti-tumor activity of recombinant interleukin-2 (rIL-2) by immunocomplexing with a monoclonal antibody against rIL-2. Biotherapy 6, 225\u2013231 (1993).","journal-title":"Biotherapy"},{"key":"25509_CR30","unstructured":"Ayoglu, B. et al. PJ. Multiplexed Autoantibody Profiles in a Systemic Sclerosis Clinical Trial Comparing Autologous Hematopoietic Stem Cell Transplantation and Cyclophosphamide [abstract]. Arthritis Rheumatol https:\/\/acrabstracts.org\/abstract\/multiplexed-autoantibody-profiles-in-a-systemic-sclerosis-clinical-trial-comparing-autologous-hematopoietic-stem-cell-transplantation-and-cyclophosphamide\/ (2018)."},{"key":"25509_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2015.00138","volume":"6","author":"JM Rosenberg","year":"2015","unstructured":"Rosenberg, J. M. & Utz, P. J. Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency. Front Immunol. 6, 138 (2015).","journal-title":"Front Immunol."},{"key":"25509_CR32","doi-asserted-by":"publisher","unstructured":"Gupta, S., Nakabo, S., Chu, J., Hasni, S. & Kaplan, M. J. Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus. medRxiv https:\/\/doi.org\/10.1101\/2020.10.29.20222000 (2020).","DOI":"10.1101\/2020.10.29.20222000"},{"key":"25509_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 22, 67\u201373 (2021).","journal-title":"Nat. Immunol."},{"key":"25509_CR34","doi-asserted-by":"publisher","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.138999 (2020).","DOI":"10.1172\/jci.insight.138999"},{"key":"25509_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","volume":"15","author":"D Nakazawa","year":"2019","unstructured":"Nakazawa, D., Masuda, S., Tomaru, U. & Ishizu, A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat. Rev. Rheumatol. 15, 91\u2013101 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"25509_CR36","doi-asserted-by":"publisher","unstructured":"Narasaraju, T. et al. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Frontiers in Pharmacology https:\/\/doi.org\/10.3389\/fphar.2020.00870 (2020).","DOI":"10.3389\/fphar.2020.00870"},{"key":"25509_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro, C. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. 220, 1\u201313 (2020).","journal-title":"Transl. Res."},{"key":"25509_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.humpath.2020.10.002","volume":"106","author":"C Magro","year":"2020","unstructured":"Magro, C. et al. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019. Hum. Pathol. 106, 106\u2013116 (2020).","journal-title":"Hum. Pathol"},{"key":"25509_CR39","doi-asserted-by":"publisher","unstructured":"Casciola-Rosen, L. et al. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv https:\/\/doi.org\/10.1101\/2020.10.13.20211664 (2020).","DOI":"10.1101\/2020.10.13.20211664"},{"key":"25509_CR40","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/ar3012","volume":"12","author":"Y Takahashi","year":"2010","unstructured":"Takahashi, Y., Haga, S., Ishizaka, Y. & Mimori, A. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res. Ther. 12, R85 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"25509_CR41","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff, M. C. et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 21, 1506\u20131516 (2020).","journal-title":"Nat. Immunol."},{"key":"25509_CR42","doi-asserted-by":"publisher","unstructured":"Kaneko, N. et al. The loss of Bcl-6 expressing T follicular helper cells and the absence of Germinal centers in COVID-19. Cell https:\/\/doi.org\/10.2139\/ssrn.3652322 (2020).","DOI":"10.2139\/ssrn.3652322"},{"key":"25509_CR43","doi-asserted-by":"publisher","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","volume":"5","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes, L. et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 5, eabd7114 (2020).","journal-title":"Sci. Immunol."},{"key":"25509_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.chom.2020.09.002","volume":"28","author":"SCA Nielsen","year":"2020","unstructured":"Nielsen, S. C. A. et al. B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host & Microbe. 28, 516\u2013525.e5 (2020).","journal-title":"Cell Host & Microbe"},{"key":"25509_CR45","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"25509_CR46","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","volume":"177","author":"CW Davis","year":"2019","unstructured":"Davis, C. W. et al. Longitudinal analysis of the human B cell response to ebola virus infection. Cell 177, 1566\u20131582.e1517 (2019).","journal-title":"Cell"},{"key":"25509_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2015.06.013","volume":"43","author":"R Di Niro","year":"2015","unstructured":"Di Niro, R. et al. Salmonella infection drives promiscuous B cell activation followed by extrafollicular affinity maturation. Immunity 43, 120\u2013131 (2015).","journal-title":"Immunity"},{"key":"25509_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739.e726 (2018).","journal-title":"Immunity"},{"key":"25509_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171\u20131177 (2005).","journal-title":"J. Exp. Med."},{"key":"25509_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.22.012703.104514","volume":"25","author":"A Marshak-Rothstein","year":"2007","unstructured":"Marshak-Rothstein, A. & Rifkin, I. R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25, 419\u2013441 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"25509_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"19","author":"RS Fujinami","year":"2006","unstructured":"Fujinami, R. S., von Herrath, M. G., Christen, U. & Whitton, J. L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 19, 80\u201394 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"25509_CR52","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.2414848","volume":"230","author":"RS Fujinami","year":"1985","unstructured":"Fujinami, R. S. & Oldstone, M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043\u20131045 (1985).","journal-title":"Science"},{"key":"25509_CR53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2017.07.026","volume":"170","author":"SE Degn","year":"2017","unstructured":"Degn, S. E. et al. Clonal evolution of autoreactive Germinal centers. Cell 170, 913\u2013926.e919 (2017).","journal-title":"Cell"},{"key":"25509_CR54","doi-asserted-by":"publisher","unstructured":"Sng, J. et al. AIRE expression controls the peripheral selection of autoreactive B cells. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aav6778 (2019).","DOI":"10.1126\/sciimmunol.aav6778"},{"key":"25509_CR55","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1073\/pnas.1518553113","volume":"113","author":"B Ayoglu","year":"2016","unstructured":"Ayoglu, B. et al. Anoctamin 2 identified as an autoimmune target in multiple sclerosis. Proc. Natl Acad. Sci. USA 113, 2188\u20132193 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25509_CR56","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1172\/JCI91162","volume":"126","author":"JE Walter","year":"2016","unstructured":"Walter, J. E. et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J. Clin. Invest 126, 4389 (2016).","journal-title":"J. Clin. Invest"},{"key":"25509_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/msb.2013.15","volume":"9","author":"D Furman","year":"2013","unstructured":"Furman, D. et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 9, 659 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"25509_CR58","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1073\/pnas.1518553113","volume":"113","author":"B Ayoglu","year":"2016","unstructured":"Ayoglu, B. et al. Anoctamin 2 identified as an autoimmune target in multiple sclerosis. Proc. Natl Acad. Sci. 113, 2188\u20132193 (2016).","journal-title":"Proc. Natl Acad. Sci."},{"key":"25509_CR59","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"25509_CR60","doi-asserted-by":"publisher","unstructured":"Kuri-Cervantes, L. et al. Immunologic perturbations in severe COVID-19\/SARS-CoV-2 infection. bioRxiv https:\/\/doi.org\/10.1101\/2020.05.18.101717 (2020).","DOI":"10.1101\/2020.05.18.101717"},{"key":"25509_CR61","unstructured":"Team, R. C. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/ (2013)."},{"key":"25509_CR62","doi-asserted-by":"crossref","unstructured":"Randad, P. R. et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J. Clin. Microbiology 59, e02204\u201320 (2020).","DOI":"10.1128\/JCM.02204-20"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25509-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:38:27Z","timestamp":1669973907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25509-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25509"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25509-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740808094.793589157","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.27.21250559","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.S. received consultancy fees and research funding from Hycor Biomedical and Thermo Fisher Scientific, research funding from Mead Johnson Nutrition (MJN), and consultancy fees from Bencard Allergie. E.J.W. has consulting agreements with and\/or is on the scientific advisory board for Merck, Elstar, Janssen, Related Sciences, Synthekine, and Surface Oncology. E.J.W. is a founder of Surface Oncology and Arsenal Biosciences. E.J.W. has a patent licensing agreement on the PD-1 pathway with Roche\/Genentech. E.M. received consultancy fees from Roche. E.T.L.P. receives research funding from Janssen Research and Development, consultancy fees, and research funding from Roche Diagnostics, is a paid consultant for Enpicom, and serves on the scientific advisory boards of the Antibody Society, the Immune Epitope Database, and the American Autoimmune Related Diseases Association. N.J.M. reports funding to her institution from Athersys Inc, Biomarck Inc, and Quantum Leap Healthcare Collaborative, outside of the funded work. S. Chinthrajah reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, FARE, and is an Advisory Board member for Alladapt, Genentech, Novartis, Sanofi, and received personal fees from Nutricia. All remaining authors declare no competing interests with the research reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5417"}}